Momenta Pharmaceuticals
MNTA
#2754
Rank
ยฃ4.63 B
Marketcap
ยฃ38.96
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Momenta Pharmaceuticals (MNTA)

Revenue in 2020 (TTM): ยฃ23.93 Million

According to Momenta Pharmaceuticals's latest financial reports the company's current revenue is ยฃ22.32 Million. In 2019 the company made a revenue of ยฃ17.72 Million a decrease over the revenue in the year 2018 that were of ยฃ56.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Momenta Pharmaceuticals from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ23.93 M35.08%
2019ยฃ17.72 M-68.42%
2018ยฃ56.12 M-45.57%
2017ยฃ0.10 B26.7%
2016ยฃ81.38 M22.28%
2015ยฃ66.56 M71.58%
2014ยฃ38.79 M47.33%
2013ยฃ26.33 M-44.52%
2012ยฃ47.45 M-77.42%
2011ยฃ0.21 B142.41%
2010ยฃ86.69 M476.68%
2009ยฃ15.03 M38.97%
2008ยฃ10.81 M-32.42%
2007ยฃ16 M31.7%
2006ยฃ12.15 M13.06%
2005ยฃ10.75 M84.86%
2004ยฃ5.81 M